Total Payments
$102,050
2024 Payments
$443.71
Companies
13
Transactions
117
Medicare Patients
2,098
Medicare Billing
$305,709
Payment Breakdown by Category
Other$92,700 (90.8%)
Food & Beverage$5,304 (5.2%)
Travel$4,046 (4.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $92,700 | 36 | 90.8% |
| Food and Beverage | $5,304 | 72 | 5.2% |
| Travel and Lodging | $4,046 | 9 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $80,983 | 51 | $0 (2024) |
| PFIZER INC. | $13,072 | 8 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $4,493 | 9 | $0 (2023) |
| Abbott Laboratories | $2,814 | 35 | $0 (2024) |
| ABIOMED | $227.41 | 2 | $0 (2024) |
| Bolton Medical Inc | $147.39 | 1 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $118.75 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $48.07 | 3 | $0 (2019) |
| Daiichi Sankyo Inc. | $44.71 | 2 | $0 (2024) |
| Amgen Inc. | $44.53 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $443.71 | 6 | ABIOMED ($227.41) |
| 2023 | $295.23 | 4 | Abbott Laboratories ($260.50) |
| 2022 | $2,586 | 5 | AstraZeneca Pharmaceuticals LP ($2,525) |
| 2021 | $12,069 | 12 | PFIZER INC. ($10,200) |
| 2020 | $647.26 | 8 | AstraZeneca Pharmaceuticals LP ($500.00) |
| 2019 | $14,140 | 16 | Novartis Pharmaceuticals Corporation ($11,201) |
| 2018 | $18,421 | 25 | Novartis Pharmaceuticals Corporation ($17,522) |
| 2017 | $53,448 | 41 | Novartis Pharmaceuticals Corporation ($52,235) |
All Payment Transactions
117 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $127.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/16/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $146.96 | General |
| Category: Heart Failure | ||||||
| 05/20/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $100.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/13/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Iron Deficiency Anemia | ||||||
| 01/31/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/12/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $121.49 | General |
| Category: NEUROMODULATION | ||||||
| 10/14/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $139.01 | General |
| Category: NEUROMODULATION | ||||||
| 07/05/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/01/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/27/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/18/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.93 | General |
| Category: Cardiovascular | ||||||
| 04/03/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $44.53 | General |
| Category: Cardiology | ||||||
| 03/31/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/29/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/22/2021 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/20/2021 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,525.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/18/2021 | Abbott Laboratories | HeartMate 3 Left Ventricular Assist Device (Device) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Heart Failure | ||||||
| 10/18/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $85.28 | General |
| Category: Heart Failure | ||||||
| 07/12/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/01/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/26/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/29/2021 | Abbott Laboratories | MitraClip System (Device) | Food and Beverage | In-kind items and services | $144.70 | General |
| Category: Structural Heart | ||||||
| 04/27/2021 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,525.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/14/2021 | Bolton Medical Inc | Relay Grafts (Device) | Food and Beverage | In-kind items and services | $147.39 | General |
| Category: Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 522 | 806 | $260,185 | $82,832 |
| 2022 | 9 | 481 | 692 | $219,535 | $68,717 |
| 2021 | 13 | 630 | 877 | $257,145 | $90,126 |
| 2020 | 10 | 465 | 716 | $183,565 | $64,034 |
Total Patients
2,098
Total Services
3,091
Medicare Billing
$305,709
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 109 | 219 | $64,440 | $24,137 | 37.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 103 | 106 | $54,970 | $17,146 | 31.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 57 | 92 | $45,540 | $13,455 | 29.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 24 | 54 | $31,695 | $10,861 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 71 | $25,645 | $8,049 | 31.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 39 | $7,830 | $2,880 | 36.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 29 | 30 | $5,990 | $2,267 | 37.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 108 | 180 | $18,000 | $2,203 | 12.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $6,075 | $1,834 | 30.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 99 | 185 | $49,950 | $17,827 | 35.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 71 | 72 | $37,080 | $13,218 | 35.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 58 | 83 | $48,140 | $12,994 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 84 | $30,240 | $9,628 | 31.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 27 | 39 | $22,620 | $8,182 | 36.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 104 | 172 | $17,200 | $2,285 | 13.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 16 | 16 | $6,480 | $1,936 | 29.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 24 | $4,680 | $1,489 | 31.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 17 | 17 | $3,145 | $1,158 | 36.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 85 | 133 | $56,285 | $21,673 | 38.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 106 | 196 | $50,895 | $18,885 | 37.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 96 | 99 | $50,130 | $18,158 | 36.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 72 | $22,295 | $8,351 | 37.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 21 | 32 | $18,560 | $6,764 | 36.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 45 | 45 | $8,175 | $3,071 | 37.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 137 | 186 | $18,600 | $2,566 | 13.8% |
About Dr. Hal Skopicki, M.D
Dr. Hal Skopicki, M.D is a Cardiovascular Disease healthcare provider based in Islandia, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346264553.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hal Skopicki, M.D has received a total of $102,050 in payments from pharmaceutical and medical device companies, with $443.71 received in 2024. These payments were reported across 117 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($92,700).
As a Medicare-enrolled provider, Skopicki has provided services to 2,098 Medicare beneficiaries, totaling 3,091 services with total Medicare billing of $305,709. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Islandia, NY
- Active Since 07/27/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1346264553
Products in Payments
- ENTRESTO (Drug) $80,958
- VYNDAQEL (Drug) $13,072
- FARXIGA (Drug) $4,475
- Circulatory Support (Device) $1,360
- HeartMate (Device) $588.34
- CARDIOMEMS (Device) $407.46
- Impella (Device) $227.41
- HeartMate 3 Left Ventricular Dev (Device) $178.11
- Relay Grafts (Device) $147.39
- MitraClip System (Device) $144.70
- PRALUENT ALIROCUMAB INJECTION (Biological) $118.75
- CardioMEMS HF System (Device) $85.28
- XARELTO (Drug) $48.07
- INJECTAFER (Drug) $44.71
- Repatha (Biological) $44.53
- Fortify Assura, Ellipse ICD (Device) $27.05
- LEQVIO (Drug) $24.63
- HeartMate 3 Left Ventricular Assist Device (Device) $23.63
- LOKELMA (Drug) $18.01
- LifeVest (Device) $18.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Islandia
Dr. William Lawson, M.d, M.D
Cardiovascular Disease — Payments: $1,468
Cardiovascular Disease $1,468
Dr. Kathleen Stergiopoulos, M.d, M.D
Cardiovascular Disease — Payments: $588.90
Cardiovascular Disease $588.90
Mr. Howard Novotny, M.d, M.D
Cardiovascular Disease — Payments: $230.27
Cardiovascular Disease $230.27
Dr. Jordan Katz, M.d, M.D
Cardiovascular Disease — Payments: $142.48
Cardiovascular Disease $142.48
Dr. Ernst Raeder, M.d, M.D
Cardiovascular Disease
Cardiovascular Disease